Department of Pharmacology, University of Washington, Seattle, WA 98195, USA.
Department of Pharmacology, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
Cell. 2020 Jan 9;180(1):122-134.e10. doi: 10.1016/j.cell.2019.11.041. Epub 2019 Dec 19.
Voltage-gated sodium channel Na1.5 generates cardiac action potentials and initiates the heartbeat. Here, we report structures of Na1.5 at 3.2-3.5 Å resolution. Na1.5 is distinguished from other sodium channels by a unique glycosyl moiety and loss of disulfide-bonding capability at the Naβ subunit-interaction sites. The antiarrhythmic drug flecainide specifically targets the central cavity of the pore. The voltage sensors are partially activated, and the fast-inactivation gate is partially closed. Activation of the voltage sensor of Domain III allows binding of the isoleucine-phenylalanine-methionine (IFM) motif to the inactivation-gate receptor. Asp and Ala, in the selectivity motif DEKA, line the walls of the ion-selectivity filter, whereas Glu and Lys are in positions to accept and release Na ions via a charge-delocalization network. Arrhythmia mutation sites undergo large translocations during gating, providing a potential mechanism for pathogenic effects. Our results provide detailed insights into Na1.5 structure, pharmacology, activation, inactivation, ion selectivity, and arrhythmias.
电压门控钠离子通道 Na1.5 产生心脏动作电位并启动心跳。在这里,我们报告了分辨率为 3.2-3.5Å 的 Na1.5 结构。Na1.5 与其他钠离子通道的区别在于其独特的糖基部分以及 Naβ 亚基相互作用位点处二硫键结合能力的丧失。抗心律失常药物氟卡尼特异性靶向孔的中央腔。电压传感器部分激活,快速失活门部分关闭。III 结构域电压传感器的激活允许异亮氨酸-苯丙氨酸-蛋氨酸(IFM)基序与失活门受体结合。DEKA 选择性基序中的天冬氨酸和丙氨酸排列在离子选择性过滤器的壁上,而谷氨酸和赖氨酸则处于通过电荷离域网络接受和释放 Na 离子的位置。心律失常突变位点在门控过程中发生大的移位,为致病效应提供了潜在的机制。我们的研究结果为 Na1.5 的结构、药理学、激活、失活、离子选择性和心律失常提供了详细的见解。